Todd W. Miller
Dartmouth College
H-index: 33
North America-United States
Top articles of Todd W. Miller
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer | Cell Reports Medicine | Meisam Bagheri Gadisti Aisha Mohamed Mohammed Ashick Mohamed Saleem Nevena B Ognjenovic Hanxu Lu | 2024/4/8 |
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer | Epigenomics | Meisam Bagheri Min Kyung Lee Kristen E Muller Todd W Miller Diwakar R Pattabiraman | 2024/3 |
TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha | Cancers | Bianca A Romo Barbara Karakyriakou Lauren Cressey Brooke L Brauer Huijuan Yang | 2024/2/20 |
Abstract PO4-01-14: Effects of neoadjuvant endocrine therapy on early-stage breast cancer: a retrospective cohort study of patients during the COVID19 pandemic | Cancer Research | Mary Chamberlin Todd Miller Marie Anne Christine Buteau Steven Tau | 2024/5/2 |
Abstract PO4-23-08: Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer | Cancer Research | Nicole Traphagen Gary Schwartz Steven Tau Alyssa Roberts Amanda Jiang | 2024/5/2 |
Neoadjuvant endocrine therapy for early-stage breast cancer: An institutional experience during the COVID19 pandemic. | Anne Christine Buteau Mary D Chamberlin Steven Tau Todd W Miller | 2023/6/1 | |
Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression | bioRxiv | Meisam Bagheri Gadisti Aisha Mohamed Mohammed Ashick Mohamed Saleem Nevena B Ognjenovic Hanxu Lu | 2023/4/21 |
Alpelisib Efficacy without Cherry-PI3King Mutations | Clinical Cancer Research | Steven Tau Todd W Miller | 2023/3/14 |
Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer | Clinical Cancer Research | Nicole A Traphagen Gary N Schwartz Steven Tau Alyssa M Roberts Amanda Jiang | 2023/9/15 |
The role of cancer cell bioenergetics in dormancy and drug resistance | Steven Tau Todd W Miller | 2023/3 | |
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer | Clinical Cancer Research | Gary N Schwartz Peter A Kaufman Karthik V Giridhar Jonathan D Marotti Mary D Chamberlin | 2023/8/1 |
Tumour, whole‐blood, plasma and tissue concentrations of metformin in lung cancer patients | British Journal of Clinical Pharmacology | Joseph D Phillips Darcy B Pooler Dylan B Ness Kayla Fay Steven Tau | 2023/3 |
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer | bioRxiv | Meisam Bagheri Min Kyung Lee Kristen E Muller Todd W Miller Diwakar R Pattabiraman | 2023/6/10 |
Abstract P4-02-12: Oxidative phosphorylation and NRF2 activation mediate resistance to estrogen deprivation in ER+ breast cancer | Cancer Research | Steven Tau Todd W Miller | 2022/2/15 |
Phase Ib study of the oral proteasome inhibitor ixazomib (MLN9708) and fulvestrant in advanced ER+ breast cancer progressing on fulvestrant | The oncologist | Gary Schwartz Kevin Shee Bianca Romo Jonathan Marotti Alexei Kisselev | 2021/6/1 |
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer | Oncogene | Nicole A Traphagen Sarah R Hosford Amanda Jiang Jonathan D Marotti Brooke L Brauer | 2021/5/13 |
Pan-Cancer Transcriptional Models Predicting Chemosensitivity in Human Tumors | Cancer Informatics | Jason D Wells Jacqueline R Griffin Todd W Miller | 2021/3 |
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America | Henry Leonidas Gomez Moreno Juan E Bargallo-Rocha Roberto J Billinghurst Aníbal R Núñez De Pierro Federico A Coló | 2021 | |
Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer | Clinical Cancer Research | Margaret L Axelrod Mellissa J Nixon Paula I Gonzalez-Ericsson Riley E Bergman Mark A Pilkinton | 2020/11/1 |
MP17-03 MICRORNA LET-7F-5P IS A NOVEL BIOMARKER OF RECURRENCE AND A POTENTIAL THERAPEUTIC OPPORTUNITY IN NON-MUSCLE INVASIVE BLADDER CANCER | The Journal of Urology | Kevin Shee* Carmen J Marsit Alan R Schned Jason Pettus David A Armstrong | 2020/4 |
